Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-03-11 @ 7:35 AM
Study NCT ID:
NCT04672434
Status:
COMPLETED
Last Update Posted:
2024-12-09
First Post:
2020-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Sponsor:
Symphogen A/S
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Locally advanced/unresectable | View |
| None | Metastatic solid tumor | View |
| None | Anti-PD-1 | View |
| None | PD-1 | View |
| None | PD1 | View |
| None | CD73 | View |
| None | Squamous cell carcinoma of the head and neck (SCCHN) | View |
| None | Non-small-cell lung carcinoma-adenocarcinoma histology subtype (NSCLC-Adeno) | View |
| None | Pancreatic ductal adenocarcinoma (PDAC) | View |
| None | Cholangiocarcinoma (CCA) | View |
| None | Colorectal carcinoma (CRC) | View |
| None | Gastric carcinoma (GC) | View |
| None | Esophageal carcinoma (EsoCA) | View |
| None | Mesothelioma (Meso) | View |
| None | Sym021 | View |
| None | Sym024 | View |
| None | Head and neck squamous cell carcinoma (HNSCC) | View |
| None | Cervical carcinoma (CC) | View |